LYON, France , Oct. 31, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2013 results announcement, which will take place on Thursday, November 21, 2013 , before the opening of the market.
LYON, France , Oct. 22, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer, Ablatherm-HIFU, will be featured in multiple presentations
Received CE mark for innovative robotic HIFU device Focal One ® Eliminated all outstanding long-term debt and strengthened financial profile Publication of long-term study reporting 10 year cancer-specific survival and metastatic-free survival rates for prostate cancer patients treated with
LYON, France , Aug. 26, 2013 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by EDAP TMS SA (Nasdaq:EDAP), please note that the presentation time should be 10:50 am ET — 11:15 am ET , rather than 10:25 am ET — 10:50 am ET as originally stated.
LYON, France , Aug. 13, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2013 results announcement, which will take place on Wednesday, August 28, 2013 , before the opening of the market.
Closes $12.0 Million Placement to Fully Redeem $8.0 Million Long-Term Debt Positions Company to Invest in Expansion of U.S. Operations LYON, France , May 29, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, outlined today the strengthening of its
LYON, France , May 21, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement of $12 million of ordinary shares in the form of
